colchicine - HEALTHY
MedPage Today: Colchicine Goes Belly-Up in a More Definitive Heart Attack Trial Any cardiovascular protection from colchicine in heart attack survivors seemed to be debunked with a better-powered randomized trial, researchers found. Between acute MI patients randomized to ... WASHINGTON — Colchicine does not protect against major cardiovascular adverse events after an acute myocardial infarction, according to a multinational placebo-controlled trial of more than 7000 ...
Context Explanation
News Medical: Colchicine does not reduce perioperative AF or MINS in major non-cardiac thoracic surgery Colchicine does not significantly reduce perioperative atrial fibrillation (AF) or myocardial injury after non-cardiac surgery (MINS) in patients undergoing major non-cardiac thoracic surgery, ... Colchicine does not reduce perioperative AF or MINS in major non-cardiac thoracic surgery Please provide your email address to receive an email when new articles are posted on . Historical use of colchicine, or its precursors, dates back several thousand years, with reports appearing in ... AMSTERDAM -- Anti-inflammatory colchicine (Lodoco) given perioperatively around major non-cardiac thoracic surgery did not cut atrial fibrillation (Afib) or myocardial injury complications, the COP-AF ...
Image Collection
Insight Material
Archives of Disease in Childhood: Paediatric colchicine poisoning in the UK: a 10-year retrospective case series from the National Poisons Information Service Objective Colchicine, derived from autumn crocus ( Colchicum autumnale ), has been used for centuries to treat arthritis. Currently, colchicine is licensed in the UK for the treatment of gout and ... Paediatric colchicine poisoning in the UK: a 10-year retrospective case series from the National Poisons Information Service Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Colchicine, an anti-inflammatory drug used to treat gout and rheumatic disease, may be a promising ... Healio: Colchicine curbs cardiovascular event risk when used with urate-lowering therapy for gout Please provide your email address to receive an email when new articles are posted on .
Related Articles You Might Like:
what symptoms for heart attack triple negative breast cancer weight watchers cookbook 2025Final Conclusion
Patients taking colchicine had a weighted hazard ratio of 0.82 (95% CI, 0.69-0.94) for cardiovascular events. Colchicine curbs cardiovascular event risk when used with urate-lowering therapy for gout PHILADELPHIA, PA—Colchicine, given orally prior to PCI in an all-comers population, does not reduce procedure-related myocardial injury, but does appear to attenuate the inflammatory response, results ... News Medical: Colchicine holds promise to reduce the risk of severe COVID-19 Colchicine is one of the oldest medicines with potent anti-inflammatory functions, widely used to treat rheumatic diseases such as gout, calcium pyrophosphate deposition disease (CPDD), and familial ...